Paxlovid于今年2月在国内获批上市,此前曾以2300元/盒的价格被临时纳入医保,低于其在美国的定价。一方面是医保支付价格的下调,但在另一方面,Paxlovid及其印度仿制药又在黑市被热炒,Paxlovid到底怎么了?“一药难求”的Paxlovid奈玛特韦片/利托那韦片组合包装(即Paxlovid)是美国辉瑞公司研发的新冠口服抗病毒药物,在...
该文核心信息如下:1)新冠特效药Paxlovid的主要用途是,预期重症或死亡风险较高的新冠感染者服用此药,如老年人或患有严重基础疾病的患者,可将住院和死亡风险降低88%;2)对缓解新冠症状无效;3)未感染时用来预防新冠也无效。所谓预期高风险患者,就是那些可能发生重症或死亡的患者,而不是已经成为重症的患者。该药还是...
Aggarwal解释说,Paxlovid在几乎所有经过评估并符合紧急使用授权(EUA)使用资格的重要门诊患者亚组中都有效地预防住院,包括那些接种过疫苗的人。Aggarwal说:“作为一名可以在门诊治疗患者的医生,在目前的Omicron阶段,无论是否接种疫苗,我都非常愿意使用Paxlovid作为急性感染COVID的成年人的一线治疗方法,只要它的使用没有禁忌...
12月13日有多家媒体报道称:新冠特效药Paxlovid(中文名称为奈玛特韦/利托那韦片)已经开放网售,定价为2980元/盒。用户在1药网旗下互联网医院的新冠咨询门诊问诊后,会被分配医生,患者上传抗原阳性照片后如被诊断为新冠病毒感染,即顺利开出Paxlovid处方。医嘱为每次口服3片,每天两次,连续服用5日,线上付款后可以快递...
COVID-19This Medical News story examines the latest information about rebound, treatment eligibility, optimal dosing, and other questions related to nirmatrelvir-ritonavir for treating COVID-19.Rubin, RitaJAMA: Journal of the American Medical Association...
As Paxlovid remains as one of the few treatments currently available to fight COVID-19, interest in the antiviral drug continues to grow, with heavy heed to its...
Anyone who watches television has probably seen the Pfizer commercial with the tagline, “If it’s COVID, Paxlovid.” That might be a catchy slogan, but, apparently, a lot of people aren’t getting the message. The US Food and Drug Administration (FDA) approved Paxlovid last ...
Many new COVID-19-specific therapies were suggested for the treatment of the patients at increased risk of progression to severe disease, especially those who were unvaccinated and those with a likely inadequate vaccine response. One of the preferred therapi...
The article “The Latest Research About Paxlovid: Effectiveness, Access, and Possible Long COVID Benefits” has a surprising but unfortunately very expected omission in the summary of the evidence for nirmatrelvir–ritonavir (Paxlovid) – the lack of any discussion of the Evaluation of Prot...
辉瑞Paxlovid因报价高医保谈判未能成功,真的有点遗憾。很多在网上叫好的,可能恰恰是自费买不起的群体。如果能入医保,很多老人可以在感染之初就能用上。不入医保需要自费的话,很多老人就不会选择早早购买,等发展到重症再用,也来不及了。#辉瑞Paxlovid因报价高医保谈判未能成功##阿兹夫定片医保谈判成功##医保局和...